Both in Pharmaceuticals
Madrigal Pharmaceuticals vs Praxis Precision Medicines
Over the past year MDGL returned −2.6% and PRAX returned +56.0%; their daily moves had a correlation of 0.25.
MDGL −2.6% PRAX +56.0%Growth of $1, one year, split-adjusted
| Metric | MDGL | PRAX |
|---|---|---|
| Price | $401.70 | $283.89 |
| Market cap | $9.28B | $7.93B |
| Today | −6.83% | +3.61% |
| 1 month | −18.6% | +0.1% |
| 6 months | −20.1% | −14.8% |
| Year to date | −31.0% | −3.7% |
| 1 year | −4.1% | +42.8% |
| Revenue growth (YoY) | +71.2% | — |
| Gross margin | 100.0% | — |
| Net margin | −15.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 7.2× | — |
| Net cash | $498.0M | $758.6M |
| Dividend yield | — | — |
| Volatility (60d) | 33.9% | 48.8% |
| Short % of float | 14.7% | 14.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).